Overview

An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants

Status:
Completed

Trial end date:
2019-04-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the experimental medication BMS-986224 in participants with varying levels of renal function.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb